Antithrombotic therapy in patients with chronic kidney disease

Circulation. 2012 May 29;125(21):2649-61. doi: 10.1161/CIRCULATIONAHA.111.084996.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Atrial Fibrillation / epidemiology
  • Chronic Disease
  • Fibrinolytic Agents / adverse effects*
  • Fibrinolytic Agents / pharmacology
  • Fibrinolytic Agents / therapeutic use*
  • Hemorrhage / epidemiology
  • Hemostasis / drug effects
  • Humans
  • Kidney Diseases / blood
  • Kidney Diseases / complications*
  • Risk Factors
  • Thromboembolism / epidemiology*

Substances

  • Fibrinolytic Agents